BPTSY
Price
$3.05
Change
+$0.01 (+0.33%)
Updated
Dec 18 closing price
RNAZ
Price
$3.76
Change
-$0.09 (-2.34%)
Updated
Dec 20 closing price
Ad is loading...

BPTSY vs RNAZ

Header iconBPTSY vs RNAZ Comparison
Open Charts BPTSY vs RNAZBanner chart's image
Biophytis SA
Price$3.05
Change+$0.01 (+0.33%)
Volume$255
CapitalizationN/A
TransCode Therapeutics
Price$3.76
Change-$0.09 (-2.34%)
Volume$76.85K
CapitalizationN/A
BPTSY vs RNAZ Comparison Chart
Loading...
BPTSY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPTSY vs. RNAZ commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPTSY is a Hold and RNAZ is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (BPTSY: $3.05 vs. RNAZ: $3.76)
Brand notoriety: BPTSY and RNAZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPTSY: 58% vs. RNAZ: 171%
Market capitalization -- BPTSY: $2.58M vs. RNAZ: $2.57M
BPTSY [@Biotechnology] is valued at $2.58M. RNAZ’s [@Biotechnology] market capitalization is $2.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPTSY’s FA Score shows that 0 FA rating(s) are green whileRNAZ’s FA Score has 1 green FA rating(s).

  • BPTSY’s FA Score: 0 green, 5 red.
  • RNAZ’s FA Score: 1 green, 4 red.
According to our system of comparison, BPTSY is a better buy in the long-term than RNAZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPTSY’s TA Score shows that 2 TA indicator(s) are bullish while RNAZ’s TA Score has 3 bullish TA indicator(s).

  • BPTSY’s TA Score: 2 bullish, 4 bearish.
  • RNAZ’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, RNAZ is a better buy in the short-term than BPTSY.

Price Growth

BPTSY (@Biotechnology) experienced а -16.44% price change this week, while RNAZ (@Biotechnology) price change was -49.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

RNAZ is expected to report earnings on May 23, 2023.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPTSY($2.59M) and RNAZ($2.57M) have the same market capitalization . BPTSY YTD gains are higher at: -88.631 vs. RNAZ (-98.272). RNAZ has higher annual earnings (EBITDA): -14.33M vs. BPTSY (-15.13M). BPTSY (0) and RNAZ (0) have equivalent revenues.
BPTSYRNAZBPTSY / RNAZ
Capitalization2.59M2.57M101%
EBITDA-15.13M-14.33M106%
Gain YTD-88.631-98.27290%
P/E RatioN/A0.00-
Revenue00-
Total CashN/A1.88M-
Total DebtN/A152K-
TECHNICAL ANALYSIS
Technical Analysis
BPTSYRNAZ
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
BPTSY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOON0.570.03
+4.99%
Kartoon Studios
ABSI2.990.07
+2.40%
Absci Corp
MMM129.282.15
+1.69%
3M Company
ATSG21.87-0.03
-0.14%
Air Transport Services Group
ST27.24-0.08
-0.29%
Sensata Technologies Holding plc

BPTSY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPTSY has been closely correlated with CDTX. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if BPTSY jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPTSY
1D Price
Change %
BPTSY100%
N/A
CDTX - BPTSY
92%
Closely correlated
+3.15%
NGNE - BPTSY
38%
Loosely correlated
+2.56%
RNAZ - BPTSY
36%
Loosely correlated
-2.34%
VRCA - BPTSY
27%
Poorly correlated
+2.65%
BRNS - BPTSY
26%
Poorly correlated
+8.82%
More

RNAZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAZ has been loosely correlated with NGNE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RNAZ jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAZ
1D Price
Change %
RNAZ100%
-2.34%
NGNE - RNAZ
48%
Loosely correlated
+2.56%
ABCZF - RNAZ
37%
Loosely correlated
N/A
BPTSY - RNAZ
33%
Poorly correlated
N/A
AGEN - RNAZ
32%
Poorly correlated
+2.54%
EDSA - RNAZ
31%
Poorly correlated
-1.14%
More